130 related articles for article (PubMed ID: 11522630)
1. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
2. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
3. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
4. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
[TBL] [Abstract][Full Text] [Related]
5. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
6. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
[TBL] [Abstract][Full Text] [Related]
7. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of lymphomagenesis by methylnitrosourea in mice transgenic for LMO1 is blocked by O6-alkylguanine DNA-alkyltransferase.
Allay E; Reese JS; McGuire EA; Koç ON; Sedransk N; Gerson SL
Oncogene; 1997 Oct; 15(17):2127-32. PubMed ID: 9366529
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain.
Jacobs H; Ossendorp F; de Vries E; Ungewiss K; von Boehmer H; Borst J; Berns A
Oncogene; 1996 May; 12(10):2089-99. PubMed ID: 8668334
[TBL] [Abstract][Full Text] [Related]
10. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
11. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
[TBL] [Abstract][Full Text] [Related]
12. Irradiation-induced rescue of thymocyte differentiation and V(D)J recombination in mice lacking the catalytic subunit of DNA-dependent protein kinase.
Wang C; Bogue MA; Nguyen AP; Roth DB
J Immunol; 1999 Dec; 163(11):6065-71. PubMed ID: 10570295
[TBL] [Abstract][Full Text] [Related]
13. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus.
Eyquem S; Chemin K; Fasseu M; Bories JC
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15712-7. PubMed ID: 15496469
[TBL] [Abstract][Full Text] [Related]
14. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
15. SCL, the gene implicated in human T-cell leukaemia, is oncogenic in a murine T-lymphocyte cell line.
Elwood NJ; Cook WD; Metcalf D; Begley CG
Oncogene; 1993 Nov; 8(11):3093-101. PubMed ID: 8414511
[TBL] [Abstract][Full Text] [Related]
16. The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11).
Valge-Archer V; Forster A; Rabbitts TH
Oncogene; 1998 Dec; 17(24):3199-202. PubMed ID: 9872335
[TBL] [Abstract][Full Text] [Related]
17. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
18. At the crossroads: diverse roles of early thymocyte transcriptional regulators.
Anderson MK
Immunol Rev; 2006 Feb; 209():191-211. PubMed ID: 16448544
[TBL] [Abstract][Full Text] [Related]
19. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia.
Elwood NJ; Begley CG
Cell Growth Differ; 1995 Jan; 6(1):19-25. PubMed ID: 7718483
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.
Chervinsky DS; Lam DH; Zhao XF; Melman MP; Aplan PD
Leukemia; 2001 Jan; 15(1):141-7. PubMed ID: 11243382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
